BodaciousBabe: Your post is right on target and well argued. Any figure over $5 million will be welcome, and will demonstrate astonishing month-by-month performance this year. Further development of compound pharmacy distribution will be a top item on the company agenda, Incidentally, it's hard for skeptics of any stripe to argue against revenue growth of the kind we have been seeing.